Malcolm R. Alison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Malcolm R. Alison has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Richard Poulsom
Histopathology Unit, Cancer Research (UK), London WC2A 3PX, UK
7 shared publications- Nicholas A. Wright
Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK
3 shared publications Pamela Vig
Histopathology Unit, Cancer Research (UK), London WC2A 3PX, UK
2 shared publicationsRosemary Jeffery
Histopathology Unit, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, UK
2 shared publicationsStuart Forbes
Department of Medicine, Faculty of Medicine, Imperial College of Science, Technology and Medicine (ICSTM), St Mary's Hospital, London, UK
2 shared publications- Stuart John Forbes
University of Edinburgh
2 shared publications
Latest Publications
- Open Access
- 15 February 2003
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 116 (4) , 599-603
Plastic adult stem cells: will they graduate from the school of hard knocks?
Notwithstanding the fact that adult bone marrow cell engraftment to epithelial organs seems a somewhat uncommon event, there is no doubt it does occur, and under appropriate conditions of a strong and positive selection pressure these cells will expand clonally and make a significant contribution to tissue replacement. Likewise, bone-marrow-derived cells can be amplified in vitro and differentiated into a multitude of tissues. These in essence are the goals of regenerative medicine using any source of stem cells, be it embryonic or adult. Despite such irrefutable evidence of what is possible, a veritable chorus of detractors of adult stem cell plasticity has emerged, some doubting its very existence, motivated perhaps by more than a little self-interest. The issues that have led to this state of affairs have included the inability to reproduce certain widely quoted data, one case where the apparent transdifferentiation was due to contamination of the donor tissue with haematopoietic cells and, most notoriously, extrapolating from the behaviour of embryonic stem cells to suggest that adult bone marrow cells simply fuse with other cells and adopt their phenotype. While these issues need resolving,slamming this whole new field because not everything is crystal clear is not good science. The fact that a phenomenon is quite rare in no way mitigates against its very existence: asteroid collisions with the Earth are rare, but try telling the dinosaurs they do not occur! When such events do occur(transdifferentiation or collision), they certainly can make an impact.
- 15 February 2003
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 116 (4) , 599-603
Open AccessPlastic adult stem cells: will they graduate from the school of hard knocks?
Notwithstanding the fact that adult bone marrow cell engraftment to epithelial organs seems a somewhat uncommon event, there is no doubt it does occur, and under appropriate conditions of a strong and positive selection pressure these cells will expand clonally and make a significant contribution to tissue replacement. Likewise, bone-marrow-derived cells can be amplified in vitro and differentiated into a multitude of tissues. These in essence are the goals of regenerative medicine using any source of stem cells, be it embryonic or adult. Despite such irrefutable evidence of what is possible, a veritable chorus of detractors of adult stem cell plasticity has emerged, some doubting its very existence, motivated perhaps by more than a little self-interest. The issues that have led to this state of affairs have included the inability to reproduce certain widely quoted data, one case where the apparent transdifferentiation was due to contamination of the donor tissue with haematopoietic cells and, most notoriously, extrapolating from the behaviour of embryonic stem cells to suggest that adult bone marrow cells simply fuse with other cells and adopt their phenotype. While these issues need resolving,slamming this whole new field because not everything is crystal clear is not good science. The fact that a phenomenon is quite rare in no way mitigates against its very existence: asteroid collisions with the Earth are rare, but try telling the dinosaurs they do not occur! When such events do occur(transdifferentiation or collision), they certainly can make an impact.
- 1 December 2002
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 13 (6) , 385-387
Liver regeneration with reference to stem cells
- 1 December 2002
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 13 (6) , 385-387
Liver regeneration with reference to stem cells
- 1 November 2002
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (7) , 2702-2705
Hepatic stem cells
- 1 November 2002
- Published by Elsevier in Transplantation Proceedings
- Vol. 34 (7) , 2702-2705
Hepatic stem cells
- 27 June 2002
- Published by Wiley in The Journal of Pathology
- Vol. 197 (4) , 419-423
An introduction to stem cells
1998 saw the publication of two papers describing the growth in vitro of human embryonic stem (ES) cells derived either from the inner cell mass (ICM) of the early blastocyst or the primitive gonadal regions of early aborted fetuses. Work on murine ES cells over many years had already established the amazing flexibility of ES cells, essentially able to differentiate into almost all cells that arise from the three germ layers. The realization of such pluripotentiality (see below) has, of course, resulted in the field of stem cell research going into overdrive, the establishment of many new biotechnology companies (http://www.stemcellresearchnew.com/catalog1677.html), and a genuine belief that stem cell research will deliver a revolution in terms of how we treat cardiovascular disease, neurodegenerative disease, cancer, diabetes, and the like. However, many people believe that early human embryos should be accorded the same status as any sentient being and thus their ‘harvesting’ for stem cells is morally unjustifiable. With this in mind, other sources of malleable stem cells have been sought. In the adult, organ formation and regeneration was thought to occur through the action of organ‐ or tissue‐restricted stem cells (i.e. haematopoietic stem cells giving rise to all the cells of the blood, neural stem cells making neurons, astrocytes, and oligodendrocytes). However, it is now believed that stem cells from one organ system, for example the haematopoietic compartment can develop into the differentiated cells within another organ system, such as the liver, brain or kidney. Thus, certain adult stem cells may turn out be as malleable as ES cells and so also be useful in regenerative medicine. This brief overview summarizes the important attributes of tissue‐based stem cells and clarifies the terms used. Copyright © 2002 John Wiley & Sons, Ltd.
- 27 June 2002
- Published by Wiley in The Journal of Pathology
- Vol. 197 (4) , 419-423
An introduction to stem cells
1998 saw the publication of two papers describing the growth in vitro of human embryonic stem (ES) cells derived either from the inner cell mass (ICM) of the early blastocyst or the primitive gonadal regions of early aborted fetuses. Work on murine ES cells over many years had already established the amazing flexibility of ES cells, essentially able to differentiate into almost all cells that arise from the three germ layers. The realization of such pluripotentiality (see below) has, of course, resulted in the field of stem cell research going into overdrive, the establishment of many new biotechnology companies (http://www.stemcellresearchnew.com/catalog1677.html), and a genuine belief that stem cell research will deliver a revolution in terms of how we treat cardiovascular disease, neurodegenerative disease, cancer, diabetes, and the like. However, many people believe that early human embryos should be accorded the same status as any sentient being and thus their ‘harvesting’ for stem cells is morally unjustifiable. With this in mind, other sources of malleable stem cells have been sought. In the adult, organ formation and regeneration was thought to occur through the action of organ‐ or tissue‐restricted stem cells (i.e. haematopoietic stem cells giving rise to all the cells of the blood, neural stem cells making neurons, astrocytes, and oligodendrocytes). However, it is now believed that stem cells from one organ system, for example the haematopoietic compartment can develop into the differentiated cells within another organ system, such as the liver, brain or kidney. Thus, certain adult stem cells may turn out be as malleable as ES cells and so also be useful in regenerative medicine. This brief overview summarizes the important attributes of tissue‐based stem cells and clarifies the terms used. Copyright © 2002 John Wiley & Sons, Ltd.
- Open Access
- 27 June 2002
- Published by Wiley in The Journal of Pathology
- Vol. 197 (4) , 417-418
Preface to stem cells
- 27 June 2002
- Published by Wiley in The Journal of Pathology
- Vol. 197 (4) , 417-418
Open AccessPreface to stem cells
- 10 June 2002
- Published by Wiley in The Journal of Pathology
- Vol. 198 (1) , 69-76
The expression of E‐cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients
Familial adenomatous polyposis patients (FAP) harbour a germline mutation of the adenomatous polyposis coli gene (APC), and APC mutations are early events in the development of sporadic colorectal neoplasms. The APC protein interacts with β‐catenin and γ‐catenin and APC mutations are believed to play a role in the altered levels of β‐catenin in colorectal tumours. Immunohistochemical studies have shown changes in the expression and distribution of E‐cadherin and catenins in sporadic colorectal neoplasms. This study assessed the expression and distribution of E‐cadherin and catenins in colorectal neoplasms and non‐neoplastic mucosa from FAP patients. The expression and cellular distribution of E‐cadherin and catenins were studied by immunohistochemistry in 61 adenomas, five carcinomas, and non‐neoplastic mucosa from 18 FAP patients. mRNA levels in the carcinomas were studied by in situ hybridization. The expression of E‐cadherin and catenins was increased in over 80% of the adenomas, with evident cytoplasmic immunoreactivity. There was increased expression of E‐cadherin and catenin in the carcinomas, with a notable increase in the levels of mRNA, in comparison with the non‐neoplastic mucosa. Copyright © 2002 John Wiley & Sons, Ltd.
- 10 June 2002
- Published by Wiley in The Journal of Pathology
- Vol. 198 (1) , 69-76
The expression of E‐cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients
Familial adenomatous polyposis patients (FAP) harbour a germline mutation of the adenomatous polyposis coli gene (APC), and APC mutations are early events in the development of sporadic colorectal neoplasms. The APC protein interacts with β‐catenin and γ‐catenin and APC mutations are believed to play a role in the altered levels of β‐catenin in colorectal tumours. Immunohistochemical studies have shown changes in the expression and distribution of E‐cadherin and catenins in sporadic colorectal neoplasms. This study assessed the expression and distribution of E‐cadherin and catenins in colorectal neoplasms and non‐neoplastic mucosa from FAP patients. The expression and cellular distribution of E‐cadherin and catenins were studied by immunohistochemistry in 61 adenomas, five carcinomas, and non‐neoplastic mucosa from 18 FAP patients. mRNA levels in the carcinomas were studied by in situ hybridization. The expression of E‐cadherin and catenins was increased in over 80% of the adenomas, with evident cytoplasmic immunoreactivity. There was increased expression of E‐cadherin and catenin in the carcinomas, with a notable increase in the levels of mRNA, in comparison with the non‐neoplastic mucosa. Copyright © 2002 John Wiley & Sons, Ltd.
- Open Access
- 30 May 2002
- Published by Wiley in The Journal of Pathology
- Vol. 197 (4) , 510-518
Hepatic stem cells
The liver in an adult healthy body maintains a balance between cell gain and cell loss. Though normally proliferatively quiescent, hepatocyte loss such as that caused by partial hepatectomy, uncomplicated by virus infection or inflammation, invokes a rapid regenerative response to restore liver mass. This restoration of moderate cell loss and ‘wear and tear’ renewal is largely achieved by hepatocyte self‐replication. Furthermore, hepatocyte transplants in animals have shown that a certain proportion of hepatocytes can undergo significant clonal expansion, suggesting that hepatocytes themselves are the functional stem cells of the liver. More severe liver injury can activate a potential stem cell compartment located within the intrahepatic biliary tree, giving rise to cords of bipotential so‐called oval cells within the lobules that can differentiate into hepatocytes and biliary epithelial cells. A third population of stem cells with hepatic potential resides in the bone marrow; these haematopoietic stem cells can contribute to the albeit low renewal rate of hepatocytes, make a more significant contribution to regeneration, and even completely restore normal function in a murine model of hereditary tyrosinaemia. How these three stem cell populations integrate together to achieve a homeostatic balance is not known. This review focuses on two major aspects of liver stem cell biology: firstly, the identity of the liver stem cells, and secondly, their potential value in the treatment of major liver disease. Copyright © 2002 John Wiley & Sons, Ltd.
- 30 May 2002
- Published by Wiley in The Journal of Pathology
- Vol. 197 (4) , 510-518
Open AccessHepatic stem cells
The liver in an adult healthy body maintains a balance between cell gain and cell loss. Though normally proliferatively quiescent, hepatocyte loss such as that caused by partial hepatectomy, uncomplicated by virus infection or inflammation, invokes a rapid regenerative response to restore liver mass. This restoration of moderate cell loss and ‘wear and tear’ renewal is largely achieved by hepatocyte self‐replication. Furthermore, hepatocyte transplants in animals have shown that a certain proportion of hepatocytes can undergo significant clonal expansion, suggesting that hepatocytes themselves are the functional stem cells of the liver. More severe liver injury can activate a potential stem cell compartment located within the intrahepatic biliary tree, giving rise to cords of bipotential so‐called oval cells within the lobules that can differentiate into hepatocytes and biliary epithelial cells. A third population of stem cells with hepatic potential resides in the bone marrow; these haematopoietic stem cells can contribute to the albeit low renewal rate of hepatocytes, make a more significant contribution to regeneration, and even completely restore normal function in a murine model of hereditary tyrosinaemia. How these three stem cell populations integrate together to achieve a homeostatic balance is not known. This review focuses on two major aspects of liver stem cell biology: firstly, the identity of the liver stem cells, and secondly, their potential value in the treatment of major liver disease. Copyright © 2002 John Wiley & Sons, Ltd.
- 21 December 2001
- Published by Wiley in Liver International
- Vol. 21 (6) , 367-373
Update on hepatic stem cells
The liver, like most organs in an adult healthy body, maintains a perfect balance between cell gain and cell loss. Though normally proliferatively quiescent, simple hepatocyte loss such as that caused by partial hepatectomy, uncomplicated by virus infection or inflammation, invokes a rapid regenerative response to restore liver mass. This restoration of moderate cell loss and ‘wear and tear’ renewal is largely achieved by hepatocyte self‐replication. Furthermore, cell transplant models have shown that hepatocytes can undergo significant clonal expansion. Such observations indicate that hepatocytes are the functional stem cells of the liver. More severe liver injury activates a facultative stem cell compartment located within the intrahepatic biliary tree, giving rise to cords of biliary epithelia within the lobules before these cells differentiate into hepatocytes. A third population of stem cells with hepatic potential resides in the bone marrow; these haematopoietic stem cells can contribute to the albeit low renewal rate of hepatocytes, make a more significant contribution to regeneration, and even completely restore normal function in a murine model of hereditary tyrosinaemia. How these three stem cell populations integrate to achieve a homeostatic balance is not understood. This review focuses on three aspects of liver stem cell biology: 1) the hepatic stem cell candidates; 2) models of cell transplantation into the liver; and 3) the therapeutic potential of hepatic stem cells.
- 21 December 2001
- Published by Wiley in Liver International
- Vol. 21 (6) , 367-373
Update on hepatic stem cells
The liver, like most organs in an adult healthy body, maintains a perfect balance between cell gain and cell loss. Though normally proliferatively quiescent, simple hepatocyte loss such as that caused by partial hepatectomy, uncomplicated by virus infection or inflammation, invokes a rapid regenerative response to restore liver mass. This restoration of moderate cell loss and ‘wear and tear’ renewal is largely achieved by hepatocyte self‐replication. Furthermore, cell transplant models have shown that hepatocytes can undergo significant clonal expansion. Such observations indicate that hepatocytes are the functional stem cells of the liver. More severe liver injury activates a facultative stem cell compartment located within the intrahepatic biliary tree, giving rise to cords of biliary epithelia within the lobules before these cells differentiate into hepatocytes. A third population of stem cells with hepatic potential resides in the bone marrow; these haematopoietic stem cells can contribute to the albeit low renewal rate of hepatocytes, make a more significant contribution to regeneration, and even completely restore normal function in a murine model of hereditary tyrosinaemia. How these three stem cell populations integrate to achieve a homeostatic balance is not understood. This review focuses on three aspects of liver stem cell biology: 1) the hepatic stem cell candidates; 2) models of cell transplantation into the liver; and 3) the therapeutic potential of hepatic stem cells.